SLC12A2 and glioma: Bioinformatic analysis showed that high glioma NKCC1 expression is associated with MAPK signaling pathways, TGF-beta signaling, and epithelial–mesenchymal transition regulation, and its expression in mesenchymal GBMs was associated with GBM patients’ shorter survival and worse prognosis [37].